Literature DB >> 20686743

Pancreatic beta cell lines and their applications in diabetes mellitus research.

Masa Skelin1, Marjan Rupnik, Avrelija Cencic.   

Abstract

During the past 30 years great effort has been put into establishing an insulin-secreting beta cell line that retains normal regulation of insulin secretion, but only few of these attempts have been successful. To overcome the limited availability of primary beta cells and to include the principles of the 3Rs into the field of diabetes mellitus research, numerous investigators used X-rays or viruses to induce insulinomas, in vitro transformation, derivation of cells from transgenic mice or even non-islet cells to produce immortalised beta cell lines. The most widely used insulin-secreting cell lines are RIN, HIT, MIN, INS-1 and TC cells. These cells produce insulin and small amounts of glucagon and somatostatin. Some of them are only poorly responsive to glucose, others respond to glucose well, but their concentration-dependence curve is markedly shifted to higher sensitivity. Despite problems associated with beta cell cultures, these cell lines have provided some valuable information about physiological processes. However, an urgent need to establish a "normal" beta cell line of human or pig origin remains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686743     DOI: 10.14573/altex.2010.2.105

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  78 in total

1.  Cell Cycle-dependent Changes in Localization and Phosphorylation of the Plasma Membrane Kv2.1 K+ Channel Impact Endoplasmic Reticulum Membrane Contact Sites in COS-1 Cells.

Authors:  Melanie M Cobb; Daniel C Austin; Jon T Sack; James S Trimmer
Journal:  J Biol Chem       Date:  2015-10-06       Impact factor: 5.157

2.  Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus.

Authors:  Raghu Ganugula; Meenakshi Arora; Patcharawalai Jaisamut; Ruedeekorn Wiwattanapatapee; Heather G Jørgensen; Vinod P Venkatpurwar; Beiyan Zhou; Aline Rodrigues Hoffmann; Rita Basu; Shaodong Guo; Naga Venkata Ravi Kumar Majeti
Journal:  Br J Pharmacol       Date:  2017-05-30       Impact factor: 8.739

Review 3.  Endoplasmic reticulum stress as the basis of obesity and metabolic diseases: focus on adipose tissue, liver, and pancreas.

Authors:  Aline Fernandes-da-Silva; Carolline Santos Miranda; Daiana Araujo Santana-Oliveira; Brenda Oliveira-Cordeiro; Camilla Rangel-Azevedo; Flávia Maria Silva-Veiga; Fabiane Ferreira Martins; Vanessa Souza-Mello
Journal:  Eur J Nutr       Date:  2021-03-19       Impact factor: 5.614

4.  Highly Selective and Potent Human β-Secretase 2 (BACE2) Inhibitors against Type 2 Diabetes: Design, Synthesis, X-ray Structure and Structure-Activity Relationship Studies.

Authors:  Arun K Ghosh; Margherita Brindisi; Yu-Chen Yen; Emma K Lendy; Satish Kovela; Emilio Leal Cárdenas; Bhavanam Sekhara Reddy; Kalapala Venketeswara Rao; Deborah Downs; Xiangping Huang; Jordan Tang; Andrew D Mesecar
Journal:  ChemMedChem       Date:  2019-02-05       Impact factor: 3.466

Review 5.  Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?

Authors:  R Carlessi; K N Keane; C Mamotte; P Newsholme
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

6.  Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells.

Authors:  Saleem Yousf; Devika M Sardesai; Abraham B Mathew; Rashi Khandelwal; Jhankar D Acharya; Shilpy Sharma; Jeetender Chugh
Journal:  Metabolomics       Date:  2019-03-29       Impact factor: 4.290

7.  Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.

Authors:  Xianyang Zhang; Tengjiao Cui; Jinlin He; Haibo Wang; Renzhi Cai; Petra Popovics; Irving Vidaurre; Wei Sha; Janine Schmid; Barbara Ludwig; Norman L Block; Stefan R Bornstein; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

8.  Fluorescent exendin-4 derivatives for pancreatic β-cell analysis.

Authors:  Susan M Clardy; Edmund J Keliher; James F Mohan; Matt Sebas; Christophe Benoist; Diane Mathis; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2013-12-20       Impact factor: 4.774

9.  Zinc deficiency alters the susceptibility of pancreatic beta cells (INS-1) to arsenic exposure.

Authors:  Annie L Cao; Laura M Beaver; Carmen P Wong; Laurie G Hudson; Emily Ho
Journal:  Biometals       Date:  2019-09-21       Impact factor: 2.949

10.  Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

Authors:  Kwang-Chul Kwon; Ramya Nityanandam; James S New; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2012-10-18       Impact factor: 9.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.